水虫(足白癬)治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR0490)
◆英語タイトル:Global Athletes Foot (Tinea pedis) Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR0490
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:91
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥526,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥789,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、水虫(足白癬)治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(インターデジタル、エロージョン、ブリスター)、用途別市場規模(子供、成人)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・水虫(足白癬)治療の市場動向
・企業の競争状況、市場シェア
・水虫(足白癬)治療の種類別市場規模(インターデジタル、エロージョン、ブリスター)
・水虫(足白癬)治療の用途別市場規模(子供、成人)
・水虫(足白癬)治療の北米市場規模2016-2027(アメリカ、カナダ)
・水虫(足白癬)治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・水虫(足白癬)治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・水虫(足白癬)治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・水虫(足白癬)治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Bausch、Quinnova Pharmaceuticals (Everett Laboratories)、Anacor Pharmaceuticals、Cardinal Health、Novartis AG、Merck、Pfizer、Medimetriks Pharmaceuticals、Medicis Pharmaceutical Corporation、Johnson and Johnson、Roche、Sanofi、Teva Pharmaceutical、Bayer Healthcare LLC)
・結論
【レポートの概要】

Market Analysis and Insights: Global Athletes Foot (Tinea pedis) Treatment Market
The global Athletes Foot (Tinea pedis) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Athletes Foot (Tinea pedis) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Athletes Foot (Tinea pedis) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Athletes Foot (Tinea pedis) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Athletes Foot (Tinea pedis) Treatment market.

Global Athletes Foot (Tinea pedis) Treatment Scope and Market Size
Athletes Foot (Tinea pedis) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Athletes Foot (Tinea pedis) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Interdigital
Erosion Type
Blister Type

Segment by Application
Children
Adult

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bausch
Quinnova Pharmaceuticals (Everett Laboratories)
Anacor Pharmaceuticals
Cardinal Health
Novartis AG
Merck
Pfizer
Medimetriks Pharmaceuticals
Medicis Pharmaceutical Corporation
Johnson and Johnson
Roche
Sanofi

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Athletes Foot (Tinea pedis) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Interdigital
1.2.3 Erosion Type
1.2.4 Blister Type
1.3 Market by Application
1.3.1 Global Athletes Foot (Tinea pedis) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Athletes Foot (Tinea pedis) Treatment Market Perspective (2016-2027)
2.2 Athletes Foot (Tinea pedis) Treatment Growth Trends by Regions
2.2.1 Athletes Foot (Tinea pedis) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Athletes Foot (Tinea pedis) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Athletes Foot (Tinea pedis) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Athletes Foot (Tinea pedis) Treatment Industry Dynamic
2.3.1 Athletes Foot (Tinea pedis) Treatment Market Trends
2.3.2 Athletes Foot (Tinea pedis) Treatment Market Drivers
2.3.3 Athletes Foot (Tinea pedis) Treatment Market Challenges
2.3.4 Athletes Foot (Tinea pedis) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Athletes Foot (Tinea pedis) Treatment Players by Revenue
3.1.1 Global Top Athletes Foot (Tinea pedis) Treatment Players by Revenue (2016-2021)
3.1.2 Global Athletes Foot (Tinea pedis) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Athletes Foot (Tinea pedis) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Athletes Foot (Tinea pedis) Treatment Revenue
3.4 Global Athletes Foot (Tinea pedis) Treatment Market Concentration Ratio
3.4.1 Global Athletes Foot (Tinea pedis) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Athletes Foot (Tinea pedis) Treatment Revenue in 2020
3.5 Athletes Foot (Tinea pedis) Treatment Key Players Head office and Area Served
3.6 Key Players Athletes Foot (Tinea pedis) Treatment Product Solution and Service
3.7 Date of Enter into Athletes Foot (Tinea pedis) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Athletes Foot (Tinea pedis) Treatment Breakdown Data by Type
4.1 Global Athletes Foot (Tinea pedis) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Athletes Foot (Tinea pedis) Treatment Forecasted Market Size by Type (2022-2027)

5 Athletes Foot (Tinea pedis) Treatment Breakdown Data by Application
5.1 Global Athletes Foot (Tinea pedis) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Athletes Foot (Tinea pedis) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Athletes Foot (Tinea pedis) Treatment Market Size (2016-2027)
6.2 North America Athletes Foot (Tinea pedis) Treatment Market Size by Type
6.2.1 North America Athletes Foot (Tinea pedis) Treatment Market Size by Type (2016-2021)
6.2.2 North America Athletes Foot (Tinea pedis) Treatment Market Size by Type (2022-2027)
6.2.3 North America Athletes Foot (Tinea pedis) Treatment Market Size by Type (2016-2027)
6.3 North America Athletes Foot (Tinea pedis) Treatment Market Size by Application
6.3.1 North America Athletes Foot (Tinea pedis) Treatment Market Size by Application (2016-2021)
6.3.2 North America Athletes Foot (Tinea pedis) Treatment Market Size by Application (2022-2027)
6.3.3 North America Athletes Foot (Tinea pedis) Treatment Market Size by Application (2016-2027)
6.4 North America Athletes Foot (Tinea pedis) Treatment Market Size by Country
6.4.1 North America Athletes Foot (Tinea pedis) Treatment Market Size by Country (2016-2021)
6.4.2 North America Athletes Foot (Tinea pedis) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Athletes Foot (Tinea pedis) Treatment Market Size (2016-2027)
7.2 Europe Athletes Foot (Tinea pedis) Treatment Market Size by Type
7.2.1 Europe Athletes Foot (Tinea pedis) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Athletes Foot (Tinea pedis) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Athletes Foot (Tinea pedis) Treatment Market Size by Type (2016-2027)
7.3 Europe Athletes Foot (Tinea pedis) Treatment Market Size by Application
7.3.1 Europe Athletes Foot (Tinea pedis) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Athletes Foot (Tinea pedis) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Athletes Foot (Tinea pedis) Treatment Market Size by Application (2016-2027)
7.4 Europe Athletes Foot (Tinea pedis) Treatment Market Size by Country
7.4.1 Europe Athletes Foot (Tinea pedis) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Athletes Foot (Tinea pedis) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Athletes Foot (Tinea pedis) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Athletes Foot (Tinea pedis) Treatment Market Size by Type
8.2.1 Asia-Pacific Athletes Foot (Tinea pedis) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Athletes Foot (Tinea pedis) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Athletes Foot (Tinea pedis) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Athletes Foot (Tinea pedis) Treatment Market Size by Application
8.3.1 Asia-Pacific Athletes Foot (Tinea pedis) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Athletes Foot (Tinea pedis) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Athletes Foot (Tinea pedis) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Athletes Foot (Tinea pedis) Treatment Market Size by Region
8.4.1 Asia-Pacific Athletes Foot (Tinea pedis) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Athletes Foot (Tinea pedis) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Athletes Foot (Tinea pedis) Treatment Market Size (2016-2027)
9.2 Latin America Athletes Foot (Tinea pedis) Treatment Market Size by Type
9.2.1 Latin America Athletes Foot (Tinea pedis) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Athletes Foot (Tinea pedis) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Athletes Foot (Tinea pedis) Treatment Market Size by Type (2016-2027)
9.3 Latin America Athletes Foot (Tinea pedis) Treatment Market Size by Application
9.3.1 Latin America Athletes Foot (Tinea pedis) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Athletes Foot (Tinea pedis) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Athletes Foot (Tinea pedis) Treatment Market Size by Application (2016-2027)
9.4 Latin America Athletes Foot (Tinea pedis) Treatment Market Size by Country
9.4.1 Latin America Athletes Foot (Tinea pedis) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Athletes Foot (Tinea pedis) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Athletes Foot (Tinea pedis) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Athletes Foot (Tinea pedis) Treatment Market Size by Type
10.2.1 Middle East & Africa Athletes Foot (Tinea pedis) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Athletes Foot (Tinea pedis) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Athletes Foot (Tinea pedis) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Athletes Foot (Tinea pedis) Treatment Market Size by Application
10.3.1 Middle East & Africa Athletes Foot (Tinea pedis) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Athletes Foot (Tinea pedis) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Athletes Foot (Tinea pedis) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Athletes Foot (Tinea pedis) Treatment Market Size by Country
10.4.1 Middle East & Africa Athletes Foot (Tinea pedis) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Athletes Foot (Tinea pedis) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bausch
11.1.1 Bausch Company Details
11.1.2 Bausch Business Overview
11.1.3 Bausch Athletes Foot (Tinea pedis) Treatment Introduction
11.1.4 Bausch Revenue in Athletes Foot (Tinea pedis) Treatment Business (2016-2021)
11.1.5 Bausch Recent Development
11.2 Quinnova Pharmaceuticals (Everett Laboratories)
11.2.1 Quinnova Pharmaceuticals (Everett Laboratories) Company Details
11.2.2 Quinnova Pharmaceuticals (Everett Laboratories) Business Overview
11.2.3 Quinnova Pharmaceuticals (Everett Laboratories) Athletes Foot (Tinea pedis) Treatment Introduction
11.2.4 Quinnova Pharmaceuticals (Everett Laboratories) Revenue in Athletes Foot (Tinea pedis) Treatment Business (2016-2021)
11.2.5 Quinnova Pharmaceuticals (Everett Laboratories) Recent Development
11.3 Anacor Pharmaceuticals
11.3.1 Anacor Pharmaceuticals Company Details
11.3.2 Anacor Pharmaceuticals Business Overview
11.3.3 Anacor Pharmaceuticals Athletes Foot (Tinea pedis) Treatment Introduction
11.3.4 Anacor Pharmaceuticals Revenue in Athletes Foot (Tinea pedis) Treatment Business (2016-2021)
11.3.5 Anacor Pharmaceuticals Recent Development
11.4 Cardinal Health
11.4.1 Cardinal Health Company Details
11.4.2 Cardinal Health Business Overview
11.4.3 Cardinal Health Athletes Foot (Tinea pedis) Treatment Introduction
11.4.4 Cardinal Health Revenue in Athletes Foot (Tinea pedis) Treatment Business (2016-2021)
11.4.5 Cardinal Health Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Athletes Foot (Tinea pedis) Treatment Introduction
11.5.4 Novartis AG Revenue in Athletes Foot (Tinea pedis) Treatment Business (2016-2021)
11.5.5 Novartis AG Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Athletes Foot (Tinea pedis) Treatment Introduction
11.6.4 Merck Revenue in Athletes Foot (Tinea pedis) Treatment Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Athletes Foot (Tinea pedis) Treatment Introduction
11.7.4 Pfizer Revenue in Athletes Foot (Tinea pedis) Treatment Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Medimetriks Pharmaceuticals
11.8.1 Medimetriks Pharmaceuticals Company Details
11.8.2 Medimetriks Pharmaceuticals Business Overview
11.8.3 Medimetriks Pharmaceuticals Athletes Foot (Tinea pedis) Treatment Introduction
11.8.4 Medimetriks Pharmaceuticals Revenue in Athletes Foot (Tinea pedis) Treatment Business (2016-2021)
11.8.5 Medimetriks Pharmaceuticals Recent Development
11.9 Medicis Pharmaceutical Corporation
11.9.1 Medicis Pharmaceutical Corporation Company Details
11.9.2 Medicis Pharmaceutical Corporation Business Overview
11.9.3 Medicis Pharmaceutical Corporation Athletes Foot (Tinea pedis) Treatment Introduction
11.9.4 Medicis Pharmaceutical Corporation Revenue in Athletes Foot (Tinea pedis) Treatment Business (2016-2021)
11.9.5 Medicis Pharmaceutical Corporation Recent Development
11.10 Johnson and Johnson
11.10.1 Johnson and Johnson Company Details
11.10.2 Johnson and Johnson Business Overview
11.10.3 Johnson and Johnson Athletes Foot (Tinea pedis) Treatment Introduction
11.10.4 Johnson and Johnson Revenue in Athletes Foot (Tinea pedis) Treatment Business (2016-2021)
11.10.5 Johnson and Johnson Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Athletes Foot (Tinea pedis) Treatment Introduction
11.11.4 Roche Revenue in Athletes Foot (Tinea pedis) Treatment Business (2016-2021)
11.11.5 Roche Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Athletes Foot (Tinea pedis) Treatment Introduction
11.12.4 Sanofi Revenue in Athletes Foot (Tinea pedis) Treatment Business (2016-2021)
11.12.5 Sanofi Recent Development
11.13 Teva Pharmaceutical
11.13.1 Teva Pharmaceutical Company Details
11.13.2 Teva Pharmaceutical Business Overview
11.13.3 Teva Pharmaceutical Athletes Foot (Tinea pedis) Treatment Introduction
11.13.4 Teva Pharmaceutical Revenue in Athletes Foot (Tinea pedis) Treatment Business (2016-2021)
11.13.5 Teva Pharmaceutical Recent Development
11.14 Bayer Healthcare LLC
11.14.1 Bayer Healthcare LLC Company Details
11.14.2 Bayer Healthcare LLC Business Overview
11.14.3 Bayer Healthcare LLC Athletes Foot (Tinea pedis) Treatment Introduction
11.14.4 Bayer Healthcare LLC Revenue in Athletes Foot (Tinea pedis) Treatment Business (2016-2021)
11.14.5 Bayer Healthcare LLC Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 水虫(足白癬)治療の世界市場規模・現状・予測2021年-2027年(Global Athletes Foot (Tinea pedis) Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。